Hi, what are you looking for?
– Glass Lewis even recommends against board motions to which Benny Landa has not objected. Please help us out : Will you offer...
See also: Teva Pharmaceuticals Denies Picking New Chairman – I am an industrialist, not a financial investor. I focus on running my own...
– The activist shareholder still fears that the Teva board won’t do what the company needs. – – “These are definitely steps in the...
– Enabling the Global Integration of the Company and Positioning It for Short- and Long-Term Value Creation. – – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA)...
– Teva investors are concerned about competition to the company’s Copaxone medication now that its patent has expired. Due to its failed attempt recently...
– The price is high because Teva considers Cipla an ideal fit. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has made a $6 billion...
– Abravanel’s is the first senior departure from Teva since Erez Vigodman became CEO. – – In the first departure from the senior management...
– (Was Originally Published at Knowlegde@Wharton) – On 11 February, when Erez Vigodman stepped into the corner office at Teva Pharmaceutical Industries, he didn’t come...
– In an email to investors seen by the “Financial Times, ” printing pioneer Benny Landa hints he is seeking to oust Teva chairman...
In a letter to the Federal Trade Commission (FTC), The American Antitrust Institute (AAI), a non-profit organization, outlined the competitive concerns raised by the proposed merger...